1.Ethical Roles of Dispute Processing Personnel in Medical Dispute
Chinese Medical Ethics 2014;(2):295-296
This paper focused on the role conflicts owing to the multiple identity of roles and professional limi -tations in the dispute processing personnel , analyzed the probability in the medical processes and results , appeal of the patients and pattern of medical dispute processing , and made the conclusion that the medical dispute processing personnel is volunteers promoting social harmony and a practitioner of new medical model from the social perspec -tive and should carry forward the dedication , fraternity, mutual assistance and progressive spirit , the concept of the biological -psychology -social medical model to analyze the loss of patients in dispute and appeal , truly safe-guard the health rights and interests of patients , and give some advices to perfect the role ethics dispute processing .
2.Sialolithiasis of the left upper lip: a case report.
Yu LUO ; Qiang ZHANG ; Chunyuan LUO ; Linlin CHEN ; Weibing TAN
West China Journal of Stomatology 2014;32(5):525-526
Sialolithiasis is a common disease of the salivary gland. This disease mainly involves the major salivary gland. Sialolithiasis of the minor salivary gland is rare. A case of sialolithiasis of the upper lip was reported, and relevant literature was reviewed in this paper.
Humans
;
Lip
;
Mouth Mucosa
;
Salivary Gland Calculi
;
Salivary Glands, Minor
3.Carcinoma ex pleomorphic adenoma occurring in the sublingual gland: a case report.
Chunyuan LUO ; Qiang ZHANG ; Linlin CHEN ; Yujiang WANG ; Weibing TAN
West China Journal of Stomatology 2014;32(4):418-419
Carcinoma ex pleomorphic adenoma occurring in the sublingual gland is extremely rare. In this report, a case of adenoid cystic carcinoma ex pleomorphic adenoma of the sublingual gland was presented.
Adenocarcinoma
;
Adenoma, Pleomorphic
;
Humans
;
Sublingual Gland
;
Sublingual Gland Neoplasms
4.Platysma myocutaneous flap with posterior based pedicle for defects in the region of parotid gland and masseter muscle
Linfin CHEN ; Xiaoxia LIU ; Weibing TAN ; Jian WU ; Qiang ZHANG ;
Chinese Archives of Otolaryngology-Head and Neck Surgery 2006;0(11):-
OBJECTIVE To assess the method and reliability of the platysma myocutaneous flap with posterior based pedicle for defects in the region of parotid gland and masseter muscle.METHODS The clinical data of 6 patients who were reconstructed with platysma myocutaneous flap with posterior based pedicle for defects in the region of parotid gland and masseter muscle from 2006 to2007 were studied. The blood supply and design of the flap,the keys in operation and the outcome after operation were also discussed.RESULTS All the patients were followed up from 2 months to one year.The color of the platysma myocutaneous flap was matched with the facial skin.All the operation results were satisfied. CONCLUSION Platysma myocutaneous flap has abundant blood supply.The operation is easy and reliable.It is suitable for reconstruction of the defects in parotid gland and masseter muscle region.
5.Ectopic recurrence of ameloblastoma in the bucca region of the mandible: a case report.
Pingfan WU ; Qiang ZHANG ; Weibing TAN ; Linlin CHEN
West China Journal of Stomatology 2013;31(5):533-535
The postoperative recurrence of ameloblastoma is common. However, ectopic recurrence in clinical operations is rare. A case of ectopic recurrence of ameloblastoma in the bucca region of the mandible after 15 years is presented in this paper. The causes of the ectopic recurrence were analyzed based on relevant literature.
Ameloblastoma
;
Cheek
;
Choristoma
;
Humans
;
Mandible
;
Mandibular Neoplasms
;
Neoplasm Recurrence, Local
;
Postoperative Period
6.Removal of benign tumor in the lower pole of the parotid gland through concealed incision in the retroauricular sulcus
WU Pingfan ; CHEN Linlin ; CHEN Fen ; GUO Lingyan ; LI Yu ; LEI Zhenge ; KE Xing ; TAN Weibing
Journal of Prevention and Treatment for Stomatological Diseases 2020;28(12):781-784
Objective :
To assess the safety and feasibility of incision in the retroauricular sulcus for removal of benign tumors in the lower pole of the parotid gland and to provide some ideas for aesthetic consideration of parotidectomy.
Methods:
In total, 18 cases with benign tumors of the lower pole regions of the parotid gland were included in this study, including 9 pleomorphic adenomas, 2 myoepitheliomas, 5 Warthin tumors, 1 basal cell adenoma and 1 oncocytoma. Three months after the operation, facial paralysis and salivary fistula were assessed. A visual analog scale was used to score the cosmetic satisfaction of the surgical incision. Tumor recurrence was followed up 6 ~ 12 months after operation.
Results:
In 18 patients with benign tumors the lower pole regions of the parotid gland, the tumor diameter ranges from 1.0 to 3.1 cm, with an average value of 2.5 cm. All patients experienced successful complete removal of the parotid mass with the minimally invasive retroauricular approach, and all wounds healed in one stage after operation. No serious complications, such as permanent facial paralysis and tumor recurrence, occurred 3 months after the operation. The patients were satisfied with the appearance of the surgical incision (aesthetic score 9.3 ± 0.4), achieving the expected aesthetic effect.
Conclusion
This approach is feasible and safe for most small benign parotid tumors located in the lower pole region of the parotid gland and in the posterior region of the jaw. The scar is located in the retroauricular sulcus, which significantly meets the aesthetic needs of the concealed incision for patients.
7.Expert consensus on clinical application of 177Lu-prostate specific membrane antigen radio-ligand therapy in prostate cancer
Guobing LIU ; Weihai ZHUO ; Yushen GU ; Zhi YANG ; Yue CHEN ; Wei FAN ; Jianming GUO ; Jian TAN ; Xiaohua ZHU ; Li HUO ; Xiaoli LAN ; Biao LI ; Weibing MIAO ; Shaoli SONG ; Hao XU ; Rong TIAN ; Quanyong LUO ; Feng WANG ; Xuemei WANG ; Aimin YANG ; Dong DAI ; Zhiyong DENG ; Jinhua ZHAO ; Xiaoliang CHEN ; Yan FAN ; Zairong GAO ; Xingmin HAN ; Ningyi JIANG ; Anren KUANG ; Yansong LIN ; Fugeng LIU ; Cen LOU ; Xinhui SU ; Lijun TANG ; Hui WANG ; Xinlu WANG ; Fuzhou YANG ; Hui YANG ; Xinming ZHAO ; Bo YANG ; Xiaodong HUANG ; Jiliang CHEN ; Sijin LI ; Jing WANG ; Yaming LI ; Hongcheng SHI
Chinese Journal of Clinical Medicine 2024;31(5):844-850
177Lu- prostate specific membrane antigen (PSMA) radio-ligand therapy has been approved abroad for advanced prostate cancer and has been in several clinical trials in China. Based on domestic clinical practice and experimental data and referred to international experience and viewpoints, the expert group forms a consensus on the clinical application of 177Lu-PSMA radio-ligand therapy in prostate cancer to guide clinical practice.